Sr One Capital Management as of March 31, 2024
Portfolio Holdings for Sr One Capital Management
Sr One Capital Management holds 6 positions in its portfolio as reported in the March 2024 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Arcellx Common Stock (ACLX) | 44.8 | $163M | 2.3M | 69.55 | |
| Crispr Therapeutics Namen Akt (CRSP) | 19.6 | $72M | 1.0M | 68.16 | |
| Silverback Therapeutics (SPRY) | 11.3 | $41M | 4.0M | 10.22 | |
| Nkarta (NKTX) | 9.9 | $36M | 3.3M | 10.81 | |
| Design Therapeutics (DSGN) | 7.2 | $26M | 6.5M | 4.03 | |
| Mineralys Therapeutics (MLYS) | 7.2 | $26M | 2.0M | 12.91 |
